Skip to main content
. 2017 Jul 11;8(45):79712–79721. doi: 10.18632/oncotarget.19161

Table 2B. Comparison of training and validation patients with recurrence.

Recurrence (N = 110) Training (N = 80) Validation (N = 30)
Age, years (median ± SD) 68.5 ± 11.9 66.0 ± 11.4
Follow-up, months (median ± SD) 47.2 ± 20.0 34.1 ± 13.9
Sex, number (%)
 Male 44 (55.0) 16 (53.3)
 Female 36 (45.0) 14 (46.7)
Stage, number (%)
 IA 10 (12.5) 8 (26.7)
 IB 44 (55.0) 11 (36.7)
 IIA 8 (10.0) 2 (6.7)
 IIB 4 (5.0) 0 (0.0)
 IIIA 14 (17.5) 9 (30.0)

SD, standard deviation.